Biotech Startup Seres Beats Suit Over Stock Drop

A Massachusetts federal judge on Friday tossed a proposed class action against a venture capital-backed Bay State biotech company, saying its optimistic outlook about a pill-based colon infection treatment did not...

Already a subscriber? Click here to view full article